Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Backstage Center DBA CTC Seller

Backstage Center DBA CTC Seller Recalls

All product recalls associated with Backstage Center DBA CTC Seller.

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

567

Class I (Serious)

25

Most Recent

Jan 2026

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 941–960 of 7756 recalls

Raiz de Tejocote Supplements (Backstage Center) - toxic ingredient (2024)

The "Alipotec King" Alipotec Raiz de Tejocote product was found to contain toxic yellow oleander instead of tejocote.

FDAFeb 23, 2024Nationwide• Backstage Center DBA CTC Seller

Surgical Tools Marketing Brochure (Baxter) – Incorrect Information (2024)

The Surgical Tools and Cardiovascular Specialty marketing brochures distributed for Flo-Rester Disposable Internal Vessel Occluder, Flo-Thru Intraluminal Shunt, and Vascular Probe Intravascular Probe contain inaccurate content that does not align with the products Instructions for Use (IFU).

FDAFeb 22, 2024Nationwide• Baxter Healthcare Corporation

Organic Carrot Juice (Barsotti) – Under Processed (2024)

Product was determined to be under processed.

1...46 474849 50...388

Page 48 of 388Next

Class II

Moderate

FDAFeb 22, 2024AZ, CA, CT +7 more• Barsotti Juice Company, Inc.

Thermalon Stye Compress (Bruder) – Moisture Exposure Risk (2024)

Thermalon and MediBeads moist heat compresses from certain lots may have been exposed to excessive moisture, resulting in potential growth of mold and/or mildew.

FDAFeb 21, 2024Nationwide• Bruder Healthcare Company, LLC

MediBeads King Pad (Bruder) – Moisture Exposure Risk (2024)

Thermalon and MediBeads moist heat compresses from certain lots may have been exposed to excessive moisture, resulting in potential growth of mold and/or mildew.

FDAFeb 21, 2024Nationwide• Bruder Healthcare Company, LLC

Thermalon Sinus Compress (Bruder) – Moisture Exposure Risk (2024)

Thermalon and MediBeads moist heat compresses from certain lots may have been exposed to excessive moisture, resulting in potential growth of mold and/or mildew.

FDAFeb 21, 2024Nationwide• Bruder Healthcare Company, LLC

Thermalon Sinus Compress French (Bruder) – Moisture Exposure Risk (2024)

Thermalon and MediBeads moist heat compresses from certain lots may have been exposed to excessive moisture, resulting in potential growth of mold and/or mildew.

FDAFeb 21, 2024Nationwide• Bruder Healthcare Company, LLC

Thermalon Heating Pad (Bruder) – Moisture Exposure Risk (2024)

Thermalon and MediBeads moist heat compresses from certain lots may have been exposed to excessive moisture, resulting in potential growth of mold and/or mildew.

FDAFeb 21, 2024Nationwide• Bruder Healthcare Company, LLC

Thermalon Eye Compress (Bruder) – Moisture Exposure Risk (2024)

Thermalon and MediBeads moist heat compresses from certain lots may have been exposed to excessive moisture, resulting in potential growth of mold and/or mildew.

FDAFeb 21, 2024Nationwide• Bruder Healthcare Company, LLC

ARCHITECT Myoglobin Reagent Kit (Abbott) – Calibration Failure (2024)

The reason for the recall is the failure of calibration and quality controls due to a manufacturing issue of microparticles not meeting labeled claim. This may lead to incorrect myoglobin results and delayed diagnosis of myocardial infarction.

FDAFeb 21, 2024Nationwide• Abbott Laboratories

Thermalon Neck Wrap (Bruder) – Moisture Exposure Risk (2024)

Thermalon and MediBeads moist heat compresses from certain lots may have been exposed to excessive moisture, resulting in potential growth of mold and/or mildew.

FDAFeb 21, 2024Nationwide• Bruder Healthcare Company, LLC

Thermalon Back Wrap (Bruder) – Moisture Exposure Risk (2024)

Thermalon and MediBeads moist heat compresses from certain lots may have been exposed to excessive moisture, resulting in potential growth of mold and/or mildew.

FDAFeb 21, 2024Nationwide• Bruder Healthcare Company, LLC

MediBeads Neck Wrap (Bruder Healthcare) – Moisture Risk (2024)

Thermalon and MediBeads moist heat compresses from certain lots may have been exposed to excessive moisture, resulting in potential growth of mold and/or mildew.

FDAFeb 21, 2024Nationwide• Bruder Healthcare Company, LLC

EndoVive PEG Kit (Boston Scientific) – Guidewire Blockage (2024)

Inability to advance the guidewire through the feeding tube during placement due to blocked lumen of the barb connector. May lead prolongation in the procedure to exchange the device for another leading to leading to a cascade of events which may include additional intervention to close the puncture site, bleeding, leakage of gastric contents, and aspiration

FDAFeb 20, 2024Nationwide• Boston Scientific Corporation

EndoVive PEG Kit (Boston Scientific) – Guidewire Blockage (2024)

Inability to advance the guidewire through the feeding tube during placement due to blocked lumen of the barb connector. May lead prolongation in the procedure to exchange the device for another leading to leading to a cascade of events which may include additional intervention to close the puncture site, bleeding, leakage of gastric contents, and aspiration

FDAFeb 20, 2024Nationwide• Boston Scientific Corporation

Obsidio Embolic (Boston Scientific) – Delivery Technique Risk (2024)

An investigation determined that delivery of the Obsidio embolic using the aliquot technique for lower gastrointestinal bleeding embolization poses a high risk of bowel ischemia. The most serious and the most common adverse health consequence, reasonably foreseeable to occur, is the need to perform major surgery such as bowel resection and/or diverting colostomy. Therefore, Boston Scientific does not recommend that the aliquot technique be used to deliver the Obsidio device for lower GI bleed embolization procedures.

FDAFeb 20, 2024Nationwide• Boston Scientific Corporation

EndoVive PEG Kit (Boston Scientific) – Guidewire Blockage (2024)

Inability to advance the guidewire through the feeding tube during placement due to blocked lumen of the barb connector. May lead prolongation in the procedure to exchange the device for another leading to leading to a cascade of events which may include additional intervention to close the puncture site, bleeding, leakage of gastric contents, and aspiration

FDAFeb 20, 2024Nationwide• Boston Scientific Corporation

Moxifloxacin Single-Dose Vial (Denver Solutions) – glass delamination (2024)

Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Class IIModerate

FDAFeb 20, 2024Nationwide• Denver Solutions, LLC DBA Leiters Health

Lidocaine HCL Solution (Denver Solutions) – glass delamination (2024)

Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Class IIModerate

FDAFeb 20, 2024Nationwide• Denver Solutions, LLC DBA Leiters Health

Moxifloxacin Balanced Salt Solution (Denver Solutions) – glass delamination (2024)

Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Class IIModerate

FDAFeb 20, 2024Nationwide• Denver Solutions, LLC DBA Leiters Health